标题
Inhibition of acute lethal pulmonary inflammation by the IDO–AhR pathway
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 29, Pages E5881-E5890
出版商
Proceedings of the National Academy of Sciences
发表日期
2017-07-04
DOI
10.1073/pnas.1615280114
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation
- (2015) A. Varelias et al. BLOOD
- -Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice
- (2015) H. Uryu et al. BLOOD
- A Distinct Function of Regulatory T Cells in Tissue Protection
- (2015) Nicholas Arpaia et al. CELL
- Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
- (2015) Ulrike M. Litzenburger et al. Oncotarget
- Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans
- (2014) S. W. Choi et al. BLOOD
- Aryl hydrocarbon receptor control of a disease tolerance defence pathway
- (2014) Alban Bessede et al. NATURE
- Current and emerging strategies for the prevention of graft-versus-host disease
- (2014) Sung Won Choi et al. Nature Reviews Clinical Oncology
- Th17/Treg Imbalance in Murine Cystic Fibrosis Is Linked to Indoleamine 2,3-Dioxygenase Deficiency but Corrected by Kynurenines
- (2013) Rossana G. Iannitti et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Alveolar Macrophages Contribute to Respiratory Tolerance by Inducing FoxP3 Expression in Naive T Cells
- (2013) Michelle M. Coleman et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Cyclosporine A Drives a Th17- and Th2-Mediated Posttransplant Obliterative Airway Disease
- (2013) P. H. Lemaître et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
- (2013) Sung Won Choi et al. LANCET ONCOLOGY
- Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection
- (2013) A. M. Jamieson et al. SCIENCE
- Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subsets
- (2012) K. A. Markey et al. BLOOD
- Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression
- (2012) Hyangin Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Alveolar Epithelial Cells in Initiating and Shaping Pulmonary Immune Responses: Communication between Innate and Adaptive Immune Systems
- (2012) Olga D. Chuquimia et al. PLoS One
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue
- (2011) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
- (2011) Maria T Pallotta et al. NATURE IMMUNOLOGY
- Histone deacetylases as regulators of inflammation and immunity
- (2011) Melanie R. Shakespear et al. TRENDS IN IMMUNOLOGY
- Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis
- (2010) M. A. Ciorba et al. JOURNAL OF IMMUNOLOGY
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality
- (2009) L. K. Jasperson et al. BLOOD
- Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease
- (2009) T. Yi et al. BLOOD
- Interferon-γ-Responsive Nonhematopoietic Cells Regulate the Immune Response to Mycobacterium tuberculosis
- (2009) Ludovic Desvignes et al. IMMUNITY
- Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice
- (2009) Denis Bedoret et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-3
- (2009) Yaping Sun et al. JOURNAL OF IMMUNOLOGY
- Interferon-γ Regulates Idiopathic Pneumonia Syndrome, a Th17+CD4+T-Cell–mediated Graft-versus-Host Disease
- (2008) Nora Mauermann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation
- (2008) G. A. Yanik et al. BLOOD
- Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease
- (2008) T. Yi et al. BLOOD
- The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
- (2008) A. Curti et al. BLOOD
- Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice
- (2008) Pavan Reddy et al. JOURNAL OF CLINICAL INVESTIGATION
- Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
- (2008) Luigina Romani et al. NATURE
- Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality
- (2007) L. K. Jasperson et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now